Martin Akerman

Martin Akerman

Company: Envisagenics

Job title: CTO


AI-Driven Discovery of Safe, Tumor-Specific Immunotherapies Through the Lenses of RNA Splicing 1:00 pm

Using AI to analyze RNA-seq data and prioritize neoepitopes encoded by tumor-specific splicing isoforms Delve into the use of biopsies from different cohorts of patients with tumor vs. normal tissues to avoid off-target effects Validated novel neoepitopes predicted with AI through a case study in triple negative breast cancerRead more

day: Day Two

Chair’s Closing Remarks 4:30 pm

Read more

day: Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.